
1. mediators inflamm. 2017;2017:6898505. doi: 10.1155/2017/6898505. epub 2017 jul
12.

morita-baylis-hillman adducts display anti-inflammatory effects modulating
inflammatory mediator expression raw264.7 cells.

faheina-martins gv(1), leite ja(2), dantas bb(1), lima-júnior cg(3), vasconcellos
mlaa(3), rodrigues-mascarenhas s(2), araújo dam(1).

author information: 
(1)laboratório de biotecnologia celular e molecular, departamento de
biotecnologia, centro de biotecnologia, universidade federal da paraíba, campus
i, joão pessoa, pb, brazil.
(2)laboratório de imunofarmacologia, departamento de biologia celular e
molecular, centro de biotecnologia, universidade federal da paraíba, campus i,
joão pessoa, pb, brazil.
(3)laboratório de síntese orgânica medicinal da paraíba (lasom-pb), departamento 
de química, universidade federal da paraíba, campus i, joão pessoa, pb, brazil.

inflammatory response plays important role normal physiology
but also pathologies cancers. morita-baylis-hillman adducts (mbha)
are novel group synthetic molecules demonstrated many biological
activities parasitic cells plasmodium falciparum, leishmania
amazonensis, leishmania chagasi, antimitotic activity sea urchin 
embryonic cells also related. however, little known mechanisms
induced mbha inflammatory process relation anticancer
activity. present work investigated cytotoxicity three mbha
derivatives (a2cn, a3cn, a4cn), human colorectal adenocarcinoma, ht-29
cells, anti-inflammatory activities examined in
lipopolysaccharide- (lps-) stimulated raw264.7 macrophage cells, these
derivatives potentially cytotoxic ht-29 cells. coincubation a2cn, a3cn,
or a4cn lps raw264.7 cells inhibited production, well the
production reactive oxygen species (ros) also repressed. mrna
expressions il-1β il-6 significantly downregulated mbha
compounds raw264.7 cells, a2cn able inhibit cox-2 gene
expression. also showed mbha compounds decreased almost zero the
production il-1β il-6. findings display mbha compounds
exhibit anticancer anti-inflammatory activities.

doi: 10.1155/2017/6898505 
pmcid: pmc5529643
pmid: 28785138  [indexed medline]

